Frailty and Steroid Treatment Outcomes in Patients with Sudden Sensorineural Hearing Loss
Annals of Otology, Rhinology & Laryngology · 2026-08 · 135 (8) · 616-623
DOI: 10.1177/00034894261435264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Otology, Rhinology & Laryngology, online erschienen am 19.04.2026. Verfasst von Lina M Adwer und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA. Hauptthemen laut MEDLINE: Dexamethasone, Hearing Loss, Sensorineural, Hearing Loss, Sudden, Frailty. Die Arbeit nennt 14 Literaturangaben.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Objective
To investigate the relationship between frailty and steroid treatment outcomes in patients with sudden sensorineural hearing loss (SSNHL). Study Design: Retrospective cohort study Setting: Tertiary-care institution. Patients: 185 adult patients (≥19 years) with unilateral SSNHL presenting January 1, 2017 to May 24, 2023, stratified by 5-Factor Modified Frailty Index (mFI5).
Interventions
Oral prednisone and/or intratympanic dexamethasone. Main Outcome Measures: Post-treatment changes in pure-tone average (PTA), speech reception threshold (SRT), and word recognition scores (WRS).
Results
Female and younger patients were significantly less frail than male and older patients ( P = .004, P < .001 respectively). Patients with higher frailty scores (≥2) were less likely to receive oral steroids (59.6% vs 82.8%, P = .004), though equally likely to receive intratympanic steroids ( P = 1.000). However, patients classified as frail (≥1) were not more likely to receive intratympanic steroids alone compared to combination therapy ( P = .220). Higher frailty scores were significantly associated with metabolic syndrome ( P = .002), but specific treatment patterns in diabetic patients could not be delineated as treatment was individualized. Dizziness ( P = .650) and vertigo ( P = .200) did not correlate with frailty or treatment outcomes. The number of comorbidities increased with higher frailty scores ( P < .001) but did not directly correlate with SSNHL outcomes. No significant differences were observed in audiometric outcomes (PTA/SRT/WRS) based on patient frailty scores across all comparisons ( P ’s > .05).
Conclusions
While we found an association between frailty scores and treatment selection for SSNHL, we did not find a significant association between frailty scores and treatment outcomes. Therefore, treatment may be individualized in frail patients without compromising audiometric outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
- Department of Otolaryngology-Head and Neck Surgery, University of Nebraska Medical Center, Omaha, NE, USA.
- College of Public Health, University of Nebraska Medical Center, Omaha, NE.
ORCID-Profile: Anne K Maxwell
Zitieren
APA
Adwer, L. M., Higgins, R. C., Lyden, E. R., & Maxwell, A. K. (2026). Frailty and Steroid Treatment Outcomes in Patients with Sudden Sensorineural Hearing Loss. Annals of Otology, Rhinology & Laryngology, 135(8), 616-623. https://doi.org/10.1177/00034894261435264
Vancouver
Adwer LM, Higgins RC, Lyden ER, Maxwell AK. Frailty and Steroid Treatment Outcomes in Patients with Sudden Sensorineural Hearing Loss. Annals of Otology, Rhinology & Laryngology. 2026;135(8):616-623. doi:10.1177/00034894261435264
BibTeX
@article{Adwer2026,
author = {Adwer, Lina M and Higgins, Ryan C and Lyden, Elizabeth R and Maxwell, Anne K},
title = {Frailty and Steroid Treatment Outcomes in Patients with Sudden Sensorineural Hearing Loss},
journal = {Annals of Otology, Rhinology & Laryngology},
year = {2026},
volume = {135},
number = {8},
pages = {616--623},
doi = {10.1177/00034894261435264}
}
EUVIMED